Pre-existing atrioventricular conduction abnormalities, membranous septum length and implant depth influence the risk of new permanent pacemaker implantation (PPI) at 30 days after transcatheter aortic valve implantation (TAVI) with the new Navitor valve, a new study subgroup analysis shows.